NYSEARCA:TMBR
Delisted

Timber Pharmaceuticals Stock Signals

etoro logo Buy TMBR
*Your capital is at risk
$0.343
+0 (+0%)
At Close: Feb 27, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Timber Pharmaceuticals Inc

General

Signal Type Signal Value Data
Score 0.000 60 days ( 0 %
Last Price $0.343 0 %
Performance History
7 Days
$0.343 $0.343
0%
30 Days
$0.343 $0.343
0%
12 Mos
$3.14 $0.343
-89.09%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 60.14
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.343 - $0.343
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Feb 26, 2024 - 2 days
RSI Short Pivot Signal Buy Very Low Dec 14, 2023 - 50 days
Short MA 3 mos Buy Low Dec 04, 2023 - 58 days
Long MA 3 mos Buy Medium Jan 16, 2024 - 30 days
Short/Long MA 3 mos Buy Medium Jan 16, 2024 - 30 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.01
Signal Type Signal Value Importance Data
Trend - 12 mos -39.33 % Very High Width: 687.70 %
Pred. range - 12 mos N/A - $1.49 High -100.00 % - 334.15 %
Short MA 12 mos Buy Very High Dec 22, 2023 - 44 days
Long MA 12 mos Sell Very High Nov 10, 2023 - 73 days
Short/Long MA 12 mos Sell Very High Nov 17, 2023 - 68 days
Pivot Long Buy Low Nov 27, 2023 - 63 days
RSI Long Pivot Signal Buy Low Dec 26, 2023 - 43 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT TIMBER PHARMACEUTICALS INC
Timber Pharmaceuticals
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary top...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE